PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAD3. A total of 7 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $5,000,000 | +2.9% | 5,000,000 | 0.0% | 0.10% | -36.5% |
Q1 2021 | $4,857,000 | +2.8% | 5,000,000 | 0.0% | 0.16% | +7.4% |
Q4 2020 | $4,727,000 | +3.5% | 5,000,000 | 0.0% | 0.15% | -21.7% |
Q3 2020 | $4,566,000 | +0.7% | 5,000,000 | 0.0% | 0.19% | -25.0% |
Q2 2020 | $4,533,000 | +1.8% | 5,000,000 | 0.0% | 0.25% | +11.5% |
Q1 2020 | $4,452,000 | +2.5% | 5,000,000 | 0.0% | 0.23% | +56.9% |
Q4 2019 | $4,345,000 | – | 5,000,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 14,407,000 | $12,813,000 | 1.42% |
ANGELO GORDON & CO., L.P. | 2,879,000 | $2,502,000 | 0.39% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 8,000,000 | $7,120,000,000 | 0.20% |
WHITEBOX ADVISORS LLC | 5,000,000 | $4,345,000 | 0.14% |
CITIGROUP INC | 7,832,000 | $6,806,000 | 0.01% |
Citadel Advisors | 3,700,000 | $3,238,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |